News

FDA chief talks staffing, abortion drug and tobacco

The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.

CBO finds health agency cuts would result in fewer new drugs

The Trump administration’s proposed cuts at the National Institutes of Health and Food and Drug Administration could lower ...

100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar

Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...

FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say

For years, inspectors have uncovered dirty equipment, contaminated supplies and fraudulent testing records in some overseas factories — serious safety and quality breaches that can sicken or kill ...

FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division

George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...
STAT18d

Inside the staff exodus and tanking morale that threaten Makary’s FDA

WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
Dermatology Advisor2d

Thousands Laid off From NIH, FDA and CDC After Supreme Court Decision

Last Monday, the U.S. Department of Health and Human Services (HHS) finalized 10,000 layoffs across federal health agencies, including the National Institutes of Health (NIH), U.S. Food and Drug ...

FDA taps biotech industry veteran as RFK Jr.'s top drug regulator

Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...

Health Cuts Would Result in Fewer Drugs for Americans, Budget Office Reports

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

Biotech exec George Tidmarsh picked as FDA's chief drug regulator

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...